Searchable abstracts of presentations at key conferences in endocrinology

ea0032p79 | Bone and Osteoporosis | ECE2013

Impact of the FRAX® tool and the NOGG guidelines on the indication of bone mineral density in Spanish postmenopausal women

Kyriakos Georgios , Casariego Alfonso Vidal , Turcios Dalia Avila , Moreno Ana Hernandez , Fernandez Alicia Calleja , Suarez Ma Dolores Blanco , Taibo Rocio Villar , Pomar Maria D. Ballesteros , Rodriguez Isidoro Cano

Introduction: The National Osteoporosis Guideline Group (NOGG) recommends determine BMD in patients who present an intermediate risk of osteoporotic fracture using the FRAX® tool, follow-up for low risk, and treatment for high risk. In 2011, 3163 BMD were performed in the Complejo Asistencial Universitario de León (CAULE). Since the cost for each BMD is 58.6* (BOCYL 31/01/2011), annual spending could rise to *185 352. The aim was to assess whether fracture risk calcu...

ea0056gp258 | Thyroid non cancer - Autoimmune Thyroid disease/pregnancy | ECE2018

Influence of levothyroxine treatment in pregnant women with thyroid antiperoxidase antibodies

Martinez Paula Fernandez , Garcia Rocio Aguado , Galindo David Emilio Barajas , Martinez Tania Ramos , Arnaiz Elena Gonzalez , Arias Sara Garcia , Ramos Mirian Alejo , Moreno Ana Hernandez , Pomar Maria Ballesteros , Rodriguez Isidoro Cano

Introduction: Thyroid antiperoxidase antibodies above the cut-off value (ATPO +) may increase the risk of maternal-foetal complications and could modify the treatment criteria. The aim of the study is to consider the impact of levothyroxine administration on maternal-foetal complications in ATPO+ pregnant women with delivery in 2016.Methods: In Leon’s health area (Spain), universal screening for gestational thyroid dysfunction is performed. ATPO + w...